2004 

M.B.B.S. 

Government Medical College and Hospital, Chandigarh 

 

2009

M.D.

PGIMER, Chandigarh 

Awards
1.     Dr Buckshey award, presented by Indian Psychiatric Society- North-Zone at 36th Annual Conference of Indian Psychiatric Society- North-Zone. Rohtak, Spetember 24-25th, 2011 (presenting author)
2.     Marfatia Award of Indian Psychiatric Society for the year 2012 presented at 65th Annual National Conference of the society, Bangalore, 10-13 Jan, 2013 (co-author)
3.     B B Sethi Award, Presented by Indian Association for Social Psychiatry at 19th National Conference of Indian Association for Social Psychiatry, Chandigarh, 23-25 November, 2012.
4.     PPA- 1 award of Indian Psychiatric Society for the year 2013 presented at 66th Annual conference of the society, Pune, 16-19 January 2014.  

1.     Life Ordinary Member of Indian Psychiatric Society
2.     Life Ordinary Member of the Indian Psychiatric Society- North Zone
3.     Life Ordinary Member of the Indian association of child and adolescent mental health
4.     Member of the Asian Federation of Early Career Psychiatrists
5.     Member of the Indian Association of Social Psychiatry
6.     Member of the Indian Association of Private psychiatry
7.     Life member of the Indian Medical Association
 

1.     Aggarwal M, Basu D. Mood disorders and anxiety disorders: How much is the overlap? And what are the implications? Journal of Mental Health and Human Behavior 2007;12:59-71
2.     Banerjee A, Mattoo SK, Aggarwal M. Alcohol dependence with seasonal bipolarity and self medication for psychotic symptoms: A case report. Journal of Mental Health and Human Behavior 2007; 12:106-108.
3.     Aggarwal M, Banerjee A, Basu D. Nosology of the substance use disorders: How deep is the ICD-DSM dichotomy? Journal of Mental Health and Human Behavior 2008;13:18-24
4.     Basu D, Aggarwal M. Mortality in patients with schizophrenia. Letter to the editor. The Lancet 2009;374:1591.
5.     Avasthi A, Aggarwal M, Grover S, Khan MKR. Research on antipsychotics in India. Indian J Psychiatry 2010;52:S317-340
6.     Avasthi A, Grover S, Aggarwal M. Research on antidepressants in India. Indian J Psychiatry 2010;52:S341-354.
7.     Avasthi A, Grover S, Aggarwal M. Research on mood stabilizers in India. Indian J Psychiatry 2010;52:S355-361.
8.     Basu D, Aggarwal M. Factors associated with medical internship. E-letter, Archives of General Psychiatry 2010. Available from URL: http://archpsyc.ama-assn.org/cgi/eletters/67/6/557.
9.     Aggarwal M, Umamaheswari V, Basu D. Legislation, society and substance use- impact of NDPS, 1985. Eastern Journal of Psychiatry 2010;13:59-64.
10.     Kate N, Grover S, Agarwal M. Does B12 deficiency lead to lack of treatment response to conventional antidepressants? Psychiatry (Edgemont) 2010;7:42-44.
11.     Kulhara P, Aggarwal M. Overview. In Psychometric assessment tools: Indian perspective of clinical psychology. Ritu Nehra and Parmanand Kulhara (eds). Indian Psychiatric Society, Chandigarh, 2011.
12.     Grover S, Aggarwal M. Long term maintenance lorazepam for catatonia: A case report. General Hospital Psychiatry 2011;33:82.e1-82.e3
13.     Aggarwal M, Avasthi A, Kumar S, Grover S. Experience of Caregiving in Schizophrenia: A study from India. International Journal of Social Psychiatry 2011;57:224-236.
14.     Grover S, Kate N, Aggarwal M, Mattoo SK, Avasthi A, Malhotra S, Kulhara P, Chakrabarti S, Basu D. Delirium in elderly: A study from a psychiatric service in North India. International Psychogeriatrics 2012;24:117-124.
15.     Aggarwal M, Grover S. Evaluation of delirium in elderly: Needs further evaluation. Letter to the editor. Geriatr Gerontol Int 2012;12:171.
16.     Grover S, Aggarwal M, Chakrabarti S, Dutt A, Avasthi A, Kulhara P, Malhotra N, Somaiya M, Chauhan N. Prevalence of Metabolic syndrome in Bipolar Disorder: an exploratory study from North India. Prog Neuropsychopharmacol Biol Psychiatry 2012;36:141-6.
17.     Grover S, Aggarwal M, Hegde A, Malhotra N, Somaiya M,Ghormode D. Electroconvulsive therapy in the presence of atrial septal defect: a case report. Journal of ECT 2012;28:e19-20.
18.     Basu D, Aggarwal M, Umamaheswari V. Narcotic drugs and Psychotropic Substances Act. In Community Mental Health in India. BS Chavan, Nitin Gupta, Priti Arun, Ajeet Sidana,Sushrut Jadhav (eds). Jaypee, Delhi 2012, pp 176-183.
19.     Aggarwal M, Grover S, Chakrabarti S, Dutt A, Avasthi A, Kulhara P. Prevalence of metabolic syndrome in unipolar depression: an exploratory study. Journal of Mental Health and Human Behavior 2012;17:15-24.
20.     Basu D, Aggarwal M, Das PP, Mattoo SK, Kulhara P, Varma VK. The shifting landscape over three decades: Changing pattern of substance abuse in patients attending a de-addiction centre in north India 1978-2008. Indian J Med Res 2012; 135:141-147
21.     Aggarwal M, Grover S, Basu D. Mobile Phone Use by Resident Doctors: Tendency to Addiction-Like Behaviour. German J Psychiatry 2012;15:50-55.
22.     Grover S, Vijay KG, Aggarwal M, Malhotra N. Catatonia associated with hyponatremia treated with ECT. J ECT 2012;28:e33-e34.
23.     Aggarwal M, Banerjee A, Singh SM, Mattoo SK, Basu D. Substance-induced psychotic disorders: 13-year data from a de-addiction centre and their clinical implications. Asian J Psychiatry 2012;5:220-4
24.     Grover S, Aggarwal M, Dutt A, Chakrabarti S, Avasthi A, Kulhara P, Somaiya M, Malhotra N, Chauhan N. Prevalence of Metabolic syndrome in Schizophrenia: an exploratory study from North India. Psychiatry Res 2012;200:1035-1037.
25.     Grover S, Hegde A, Aggarwal M, Sachdeva MS. Olanzapine associated leucopenia and thrombocytopenia managed with lithium in a patient who developed leucopenia with clozapine in the past: a case report. Primary Care Companion for CNS Disorders 2012;14(6):e1-e2.
26.     Grover S, Chakrabarti S, Aggarwal M, Avasthi A, Kulhara P, Sharma S, et al. Comparative study of the experience of caregiving in Bipolar Affective Disorder and Schizophrenia. International Journal of Social Psychiatry 2012;58:614-622.
27.     Aggarwal M, Ghai S, Basu D. Attitude of nursing students towards psychoactive substance use: does training matter? International Journal of Nursing Education 2012;4:146-150.
28.     Aneja J, Grover S, Aggarwal M, Kaushik S. Use of ECT in the presence of Glaucoma: A case report and review of literature. Indian J Psychol Med 2013;35(1):80-83.
29.     Aggarwal M, Basu D. Cognitive therapy in patients with schizophrenia. Letter to the editor. JAMA Psychiatry 2013;70 (5):543-544.
30.     Nebhinani N, Aggarwal M, Mattoo SK, Basu D. Carisoprodol: an under recognized drug of abuse in North India. Gen Hosp Psychiatry. 2013 Jan-Feb;35(1):89-92
31.     Mattoo SK, Nebhinani N, Aggarwal M, Basu D, Kulhara P. Metabolic syndrome in substance dependent men: a study from India. Ind Psychiatry J 2013; 22:60-64.
32.     Kate N, Grover S, Aggarwal M, Malhotra P, Sachdeva MS. Clozapine associated thrombocytopenia. J Pharmacol Pharmacother. 2013;4:149-51.

1.     Aggarwal M, Basu D. Mood disorders and anxiety disorders: How much is the overlap? And what are the implications? Journal of Mental Health and Human Behavior 2007;12:59-71
2.     Banerjee A, Mattoo SK, Aggarwal M. Alcohol dependence with seasonal bipolarity and self medication for psychotic symptoms: A case report. Journal of Mental Health and Human Behavior 2007; 12:106-108.
3.     Aggarwal M, Banerjee A, Basu D. Nosology of the substance use disorders: How deep is the ICD-DSM dichotomy? Journal of Mental Health and Human Behavior 2008;13:18-24
4.     Basu D, Aggarwal M. Mortality in patients with schizophrenia. Letter to the editor. The Lancet 2009;374:1591.
5.     Avasthi A, Aggarwal M, Grover S, Khan MKR. Research on antipsychotics in India. Indian J Psychiatry 2010;52:S317-340
6.     Avasthi A, Grover S, Aggarwal M. Research on antidepressants in India. Indian J Psychiatry 2010;52:S341-354.
7.     Avasthi A, Grover S, Aggarwal M. Research on mood stabilizers in India. Indian J Psychiatry 2010;52:S355-361.
8.     Basu D, Aggarwal M. Factors associated with medical internship. E-letter, Archives of General Psychiatry 2010. Available from URL: http://archpsyc.ama-assn.org/cgi/eletters/67/6/557.
9.     Aggarwal M, Umamaheswari V, Basu D. Legislation, society and substance use- impact of NDPS, 1985. Eastern Journal of Psychiatry 2010;13:59-64.
10.     Kate N, Grover S, Agarwal M. Does B12 deficiency lead to lack of treatment response to conventional antidepressants? Psychiatry (Edgemont) 2010;7:42-44.
11.     Kulhara P, Aggarwal M. Overview. In Psychometric assessment tools: Indian perspective of clinical psychology. Ritu Nehra and Parmanand Kulhara (eds). Indian Psychiatric Society, Chandigarh, 2011.
12.     Grover S, Aggarwal M. Long term maintenance lorazepam for catatonia: A case report. General Hospital Psychiatry 2011;33:82.e1-82.e3
13.     Aggarwal M, Avasthi A, Kumar S, Grover S. Experience of Caregiving in Schizophrenia: A study from India. International Journal of Social Psychiatry 2011;57:224-236.
14.     Grover S, Kate N, Aggarwal M, Mattoo SK, Avasthi A, Malhotra S, Kulhara P, Chakrabarti S, Basu D. Delirium in elderly: A study from a psychiatric service in North India. International Psychogeriatrics 2012;24:117-124.
15.     Aggarwal M, Grover S. Evaluation of delirium in elderly: Needs further evaluation. Letter to the editor. Geriatr Gerontol Int 2012;12:171.
16.     Grover S, Aggarwal M, Chakrabarti S, Dutt A, Avasthi A, Kulhara P, Malhotra N, Somaiya M, Chauhan N. Prevalence of Metabolic syndrome in Bipolar Disorder: an exploratory study from North India. Prog Neuropsychopharmacol Biol Psychiatry 2012;36:141-6.
17.     Grover S, Aggarwal M, Hegde A, Malhotra N, Somaiya M,Ghormode D. Electroconvulsive therapy in the presence of atrial septal defect: a case report. Journal of ECT 2012;28:e19-20.
18.     Basu D, Aggarwal M, Umamaheswari V. Narcotic drugs and Psychotropic Substances Act. In Community Mental Health in India. BS Chavan, Nitin Gupta, Priti Arun, Ajeet Sidana,Sushrut Jadhav (eds). Jaypee, Delhi 2012, pp 176-183.
19.     Aggarwal M, Grover S, Chakrabarti S, Dutt A, Avasthi A, Kulhara P. Prevalence of metabolic syndrome in unipolar depression: an exploratory study. Journal of Mental Health and Human Behavior 2012;17:15-24.
20.     Basu D, Aggarwal M, Das PP, Mattoo SK, Kulhara P, Varma VK. The shifting landscape over three decades: Changing pattern of substance abuse in patients attending a de-addiction centre in north India 1978-2008. Indian J Med Res 2012; 135:141-147
21.     Aggarwal M, Grover S, Basu D. Mobile Phone Use by Resident Doctors: Tendency to Addiction-Like Behaviour. German J Psychiatry 2012;15:50-55.
22.     Grover S, Vijay KG, Aggarwal M, Malhotra N. Catatonia associated with hyponatremia treated with ECT. J ECT 2012;28:e33-e34.
23.     Aggarwal M, Banerjee A, Singh SM, Mattoo SK, Basu D. Substance-induced psychotic disorders: 13-year data from a de-addiction centre and their clinical implications. Asian J Psychiatry 2012;5:220-4
24.     Grover S, Aggarwal M, Dutt A, Chakrabarti S, Avasthi A, Kulhara P, Somaiya M, Malhotra N, Chauhan N. Prevalence of Metabolic syndrome in Schizophrenia: an exploratory study from North India. Psychiatry Res 2012;200:1035-1037.
25.     Grover S, Hegde A, Aggarwal M, Sachdeva MS. Olanzapine associated leucopenia and thrombocytopenia managed with lithium in a patient who developed leucopenia with clozapine in the past: a case report. Primary Care Companion for CNS Disorders 2012;14(6):e1-e2.
26.     Grover S, Chakrabarti S, Aggarwal M, Avasthi A, Kulhara P, Sharma S, et al. Comparative study of the experience of caregiving in Bipolar Affective Disorder and Schizophrenia. International Journal of Social Psychiatry 2012;58:614-622.
27.     Aggarwal M, Ghai S, Basu D. Attitude of nursing students towards psychoactive substance use: does training matter? International Journal of Nursing Education 2012;4:146-150.
28.     Aneja J, Grover S, Aggarwal M, Kaushik S. Use of ECT in the presence of Glaucoma: A case report and review of literature. Indian J Psychol Med 2013;35(1):80-83.
29.     Aggarwal M, Basu D. Cognitive therapy in patients with schizophrenia. Letter to the editor. JAMA Psychiatry 2013;70 (5):543-544.
30.     Nebhinani N, Aggarwal M, Mattoo SK, Basu D. Carisoprodol: an under recognized drug of abuse in North India. Gen Hosp Psychiatry. 2013 Jan-Feb;35(1):89-92
31.     Mattoo SK, Nebhinani N, Aggarwal M, Basu D, Kulhara P. Metabolic syndrome in substance dependent men: a study from India. Ind Psychiatry J 2013; 22:60-64.
32.     Kate N, Grover S, Aggarwal M, Malhotra P, Sachdeva MS. Clozapine associated thrombocytopenia. J Pharmacol Pharmacother. 2013;4:149-51.